ABNX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abionyx Pharma SA

Watchlist Manager

Watchlist

Price: 1.84 EUR 1.77% Market Closed

Market Cap: €78.3m

	Abionyx Pharma SA PAR:ABNX	FR
	Cleveland-Cliffs Inc NYSE:CLF	US
	Lasertec Corp TSE:6920	JP
	Silvercrest Metals ULC TSX:SIL	CA
	CBAK Energy Technology Inc NASDAQ:CBAT	CN
G	GreenX Metals Ltd WSE:GRX	AU

Profitability Summary

Abionyx Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

13%

Sustainable 3Y Average Gross Margin

16%

Gross Margin is Increasing

11% > 13%

Negative Operating Margin

-136%

Negative 3Y Average Operating Margin

-97%

Declining Operating Margin

-82% > -136%

Negative Net Margin

-137%

Negative 3Y Average Net Margin

-97%

Declining Net Margin

-82% > -137%

Negative Free Cash Flow Margin

-78%

Negative 3Y Average Free Cash Flow Margin

-78%

Declining Free Cash Flow Margin

-52% > -78%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-48%

Declining ROIC

-35% > -66%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

13%

Sustainable 3Y Average Gross Margin

16%

Gross Margin is Increasing

11% > 13%

Negative Operating Margin

-136%

Negative 3Y Average Operating Margin

-97%

Declining Operating Margin

-82% > -136%